SCHEMBL4667136

SCHEMBL4667136

O=CCN(Cc1ccc(C(F)(F)F)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LSS P48449 1/20 0.43
SRD5A2 P31213 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
MTOR P42345 1/20 0.43
PIK3CA P42336 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
PDPK1 O15530 1/20 0.40
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
PYCR1 P32322 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1845033 0.82 HDAC3 (0.44) MEN1KMT2ALSSSLC6A2SLC6A4
SCHEMBL7965956 0.81 SMN1; SMN2 (0.46)
SCHEMBL376141 0.79 LMNA (0.52) MEN1KMT2A
SCHEMBL5069046 0.79 MEN1 (0.47) MEN1KMT2ALSSSRD5A2MTOR
SCHEMBL29190281 0.75 HDAC1 (0.60) MEN1KMT2AMTORHDAC1HDAC8
SCHEMBL3609887 0.75 HDAC6 (0.61) LSSHDAC1HDAC8
SCHEMBL4314659 0.75 KIF11 (0.53) MEN1KMT2A
SCHEMBL17801922 0.74 TSHR (0.55) MEN1KMT2A
SCHEMBL3959677 0.73 YAP1 (0.48) MEN1KMT2ALSSSRD5A2MTOR
SCHEMBL6606071 0.73 TDP1 (0.39) MEN1KMT2ACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001876-A2 8-AZABICYCLOÝ3.2.1¨OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-12-17 EP disclosed
WO-2007103187-A2 8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2007-09-13 WO disclosed